Home » Market News » DirectorsTalk Highlights » What is immunotherapy?
Avacta Group Plc

What is immunotherapy?

Immunotherapy is a standard treatment for some types of cancer, for example melanoma that has spread. And it is in trials for other types of cancer.

What is it?

Immunotherapy uses our immune system to fight cancer. It works by helping the immune system recognise and attack cancer cells.

Avacta Group Plc (LON:AVCT) offers reagents and therapeutics based on Affimer technology for diagnostic and research applications in the United Kingdom. The company’s custom Affimer products are also used in drugs and biomarkers discovery in biotech research and development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.